{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:44:29Z","timestamp":1790880269436,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.critrevonc.2025.104997","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:08:54Z","timestamp":1761696534000},"page":"104997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Liver microenvironment and therapy resistance in hepatocellular carcinoma"],"prefix":"10.1016","volume":"216","author":[{"given":"Kosar","family":"Rahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Najimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Vosough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104997_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/hep.28835","article-title":"Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332\/\u03b13 integrin axis recovery of focal adhesion kinase ubiquitination","volume":"64","author":"Azzariti","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2025.104997_bib3","first-page":"405","article-title":"Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis","volume":"32","author":"Baronzio","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2025.104997_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100056","article-title":"The Biophysics of Cancer: Emerging Insights from Micro- and Nanoscale Tools","volume":"2","author":"Beshay","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20517\/2394-5079.2016.22","article-title":"Further understanding of mechanisms involved in liver cancer chemoresistance","volume":"3","author":"Briz","year":"2017","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.critrevonc.2025.104997_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104997_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, Inflammation, and Cancer","volume":"11","author":"Deng","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib12","article-title":"Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis","volume":"28","author":"Deng","year":"2022","journal-title":"Neoplasia (U. S. )"},{"key":"10.1016\/j.critrevonc.2025.104997_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-019-1311-z","article-title":"Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of \u03b2-catenin in hepatocellular carcinoma","volume":"38","author":"Deng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/1541-7786.MCR-21-0699","article-title":"Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation","volume":"20","author":"Ding","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0038-1676121","article-title":"TGF-\u03b2 as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives","volume":"39","author":"Dituri","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.critrevonc.2025.104997_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41416-019-0482-x","article-title":"M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma","volume":"121","author":"Dong","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0185088","article-title":"Activation of phosphatidylinositol 3-kinase\/AKT\/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells","volume":"12","author":"Dong","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104997_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat"},{"key":"10.1016\/j.critrevonc.2025.104997_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.critrevonc.2025.104997_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/hep-2017-0012","article-title":"The TGF-\u03b2 pathway: a pharmacological target in hepatocellular carcinoma?","volume":"4","author":"Fabregat","year":"2017","journal-title":"Hepatic Oncol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-01924-w","article-title":"Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches","volume":"21","author":"Farzaneh","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2025.104997_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-0771-8","article-title":"Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma","volume":"19","author":"Fu","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2025.104997_bib23","first-page":"816","article-title":"Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer","volume":"20","author":"Fu","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7150\/jca.35631","article-title":"Hyperactivation of IL-6\/STAT3 pathway leaded to the poor prognosis of post-TACE HCCs by HIF-1\u03b1\/SNAI1 axis-induced epithelial to mesenchymal transition","volume":"11","author":"Gai","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib25","first-page":"3684","article-title":"Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma","volume":"9","author":"Giannelli","year":"2003","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib26","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/sj.bjc.6602231","article-title":"Laminin-5 offsets the efficacy of gefitinib ('Iressa\u2019) in hepatocellular carcinoma cells","volume":"91","author":"Giannelli","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib27","doi-asserted-by":"crossref","first-page":"C1431","DOI":"10.1152\/ajpcell.00508.2023","article-title":"Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits","volume":"325","author":"Gnocchi","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153942","article-title":"Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis","volume":"15","author":"Gnocchi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104997_bib29","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/hep4.1966","article-title":"Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironment","volume":"6","author":"Gong","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.critrevonc.2025.104997_bib30","doi-asserted-by":"crossref","first-page":"44465","DOI":"10.18632\/oncotarget.17973","article-title":"M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104997_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2021.775462","article-title":"Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges","volume":"9","author":"Hao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/14728222.2023.2293746","article-title":"XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma","volume":"27","author":"Hendi","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.critrevonc.2025.104997_bib33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","article-title":"Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion","volume":"59","author":"H\u00f6chst","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40425-018-0356-4","article-title":"Targeting the TGF\u03b2 pathway with galunisertib, a TGF\u03b2RI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade","volume":"6","author":"Holmgaard","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib35","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3892\/ijo.2016.3421","article-title":"Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1\u03b1 is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery","volume":"48","author":"Huang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","article-title":"Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance","volume":"28","author":"Iwamoto","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2025.104997_bib37","first-page":"158","article-title":"Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer","volume":"26","author":"Jia","year":"2011","journal-title":"Chin. Med. Sci. J. = Chungkuo i hsueh K. \u2019o hsueh tsa chih"},{"key":"10.1016\/j.critrevonc.2025.104997_bib38","first-page":"969","volume":"6","author":"Kalchman","year":"2012","journal-title":"MIT Open Access Artic. A threeDimens. Microfluid. Tumor Cell Migr. Assay. Screen Eff. antiMigr. Drugs Inter. Flow."},{"key":"10.1016\/j.critrevonc.2025.104997_bib39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3349\/ymj.2017.58.5.899","article-title":"Down-regulation of TGF-\u03b2 expression sensitizes the resistance of hepatocellular carcinoma cells to sorafenib","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.critrevonc.2025.104997_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-1666-1_11","article-title":"Drug Resistance in Cancer: Mechanisms and Strategies","author":"Khan","year":"2024","journal-title":"Drug Resistance Cancer Mechanisms Strategies"},{"key":"10.1016\/j.critrevonc.2025.104997_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.neo.2018.05.008","article-title":"Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma","volume":"20","author":"Khawar","year":"2018","journal-title":"Neoplasia (U. S. )"},{"key":"10.1016\/j.critrevonc.2025.104997_bib43","doi-asserted-by":"crossref","first-page":"6058147","DOI":"10.1155\/2016\/6058147","article-title":"Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment","volume":"2016","author":"Kim","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.critrevonc.2025.104997_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1445452","article-title":"pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma","volume":"7","author":"Kuchuk","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","article-title":"Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met\/FRA1\/HEY1 Signaling","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2025.104997_bib47","doi-asserted-by":"crossref","first-page":"21853","DOI":"10.18632\/oncotarget.5213","article-title":"Human CD4+ T cells require exogenous cystine for glutathione and DNA synthesis","volume":"6","author":"Levring","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104997_bib48","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/hep.26224","article-title":"Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1\u03b1 inhibition in hepatocellular carcinoma","volume":"57","author":"Liang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2016.07.013","article-title":"Inhibition of the Wnt\/\u03b2-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma","volume":"381","author":"Lin","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104997_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0742-4","article-title":"Factors involved in cancer metastasis: A better understanding to \u2018seed and soil\u2019 hypothesis","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib51","first-page":"384","article-title":"3D biomimetic tumor microenvironment of HCC to visualize the intercellular crosstalk between hepatocytes, hepatic stellate cells, and cancer cells","volume":"4","author":"Liu","year":"2023","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00109-018-1731-9","article-title":"Cancer-associated fibroblasts promote the stemness of CD24 + liver cells via paracrine signaling","volume":"97","author":"Li","year":"2019","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/bab.1302","article-title":"Role of three-dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells","volume":"62","author":"Liu","year":"2015","journal-title":"Biotechnol. Appl. Biochem"},{"key":"10.1016\/j.critrevonc.2025.104997_bib54","doi-asserted-by":"crossref","first-page":"32876","DOI":"10.18632\/oncotarget.8765","article-title":"Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104997_bib55","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1158\/1078-0432.CCR-12-0552","article-title":"Sorafenib inhibits hypoxia-inducible factor-1\u03b1 synthesis: implications for antiangiogenic activity in hepatocellular carcinoma","volume":"18","author":"Liu","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.21037\/tcr.2017.08.32","article-title":"HIF-1\u03b1 and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization","volume":"6","author":"Liu","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib57","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41419-021-04418-9","article-title":"Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2025.104997_bib58","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1038\/s41388-018-0309-x","article-title":"Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104997_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174019","article-title":"Roles and mechanisms of adipokines in drug resistance of tumor cells","volume":"899","author":"Li","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.critrevonc.2025.104997_bib60","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.30676","article-title":"Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1\u2013Chemokine (C-X-C Motif) Receptor 2 Axis","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lfs.2018.02.006","article-title":"LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells","volume":"197","author":"Li","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib62","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2025.104997_bib63","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1158\/1078-0432.CCR-11-2939","article-title":"Molecular pathways: Tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment","volume":"18","author":"Lu","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13346-012-0115-x","article-title":"Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus","volume":"3","author":"Machida","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib65","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1039\/C9BM01339C","article-title":"Opposite responses of normal hepatocytes and hepatocellular carcinoma cells to substrate viscoelasticity","volume":"8","author":"Mandal","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib66","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1158\/1078-0432.CCR-10-2538","article-title":"Cancer stem cells and chemosensitivity","volume":"17","author":"Maugeri-Sacc\u00e0","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib67","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","article-title":"CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt\/PKB survival pathway","volume":"27","author":"Ma","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104997_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020310","article-title":"Myeloid-Derived Suppressor Cells in Solid Tumors","volume":"11","author":"Ma","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2025.104997_bib69","doi-asserted-by":"crossref","first-page":"20130676","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radio."},{"key":"10.1016\/j.critrevonc.2025.104997_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","article-title":"Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors","volume":"50","author":"M\u00e9ndez-Blanco","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151284","article-title":"Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future","volume":"102","author":"Minaei","year":"2023","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CMAR.S65444","article-title":"Interstitial fluid flow in cancer: Implications for disease progression and treatment","volume":"6","author":"Munson","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.2020034987","article-title":"Significance of the Tumor Microenvironment in Liver Cancer Progression","volume":"25","author":"Muppala","year":"2020","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.critrevonc.2025.104997_bib74","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.biomaterials.2014.03.058","article-title":"Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening","volume":"35","author":"Nguyen","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2025.104997_bib75","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastas.. Rev."},{"key":"10.1016\/j.critrevonc.2025.104997_bib76","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/JHC.S342266","article-title":"Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment","volume":"9","author":"Papaconstantinou","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.critrevonc.2025.104997_bib77","doi-asserted-by":"crossref","first-page":"856","DOI":"10.21037\/atm-20-1038","article-title":"Cancer-associated fibroblasts enhance the chemoresistance of CD73+ hepatocellular carcinoma cancer cells via HGF-Met-ERK1\/2 pathway","volume":"8","author":"Peng","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib78","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104997_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-1536-6-17","article-title":"The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma","volume":"6","author":"Rombouts","year":"2013","journal-title":"Fibrogenes. Tissue Repair"},{"key":"10.1016\/j.critrevonc.2025.104997_bib80","article-title":"The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability","volume":"4","author":"Roy","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.critrevonc.2025.104997_bib81","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.32899","article-title":"Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma","volume":"147","author":"Ruan","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib82","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.aohep.2019.07.004","article-title":"Obesity and liver cancer","volume":"18","author":"Saitta","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188792","article-title":"Interstitial fluid pressure as an emerging biomarker in solid tumors","volume":"1877","author":"Salavati","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib84","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020373","article-title":"Laminin-332 \u03b32 Monomeric Chain Promotes Adhesion and Migration of Hepatocellular Carcinoma Cells","volume":"15","author":"Scialpi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104997_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-61510-4","article-title":"Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma","volume":"10","author":"Seitz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104997_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071586","article-title":"The role of tumor microenvironment in chemoresistance: To survive, keep your enemies closer","volume":"18","author":"Senthebane","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114487","article-title":"Autophagy orchestrates resistance in hepatocellular carcinoma cells","volume":"161","author":"Seydi","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.critrevonc.2025.104997_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142337","article-title":"Interstitial fluid flow increases hepatocellular carcinoma cell invasion through CXCR4\/CXCL12 and MEK\/ERK signaling","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104997_bib90","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10439-011-0252-2","article-title":"Biomechanical forces shape the tumor microenvironment","volume":"39","author":"Shieh","year":"2011","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.critrevonc.2025.104997_bib91","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib92","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1111\/jcmm.16875","article-title":"Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights","volume":"25","author":"Shokoohian","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib93","doi-asserted-by":"crossref","first-page":"rbae016","DOI":"10.1093\/rb\/rbae016","article-title":"Cancer cell response to extrinsic and intrinsic mechanical cue: opportunities for tumor apoptosis strategies","volume":"11","author":"Shu","year":"2024","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.critrevonc.2025.104997_bib94","first-page":"1","article-title":"Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids","volume":"6","author":"Song","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104997_bib95","doi-asserted-by":"crossref","first-page":"21650","DOI":"10.18632\/oncotarget.15521","article-title":"TGF-\u03b2-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104997_bib96","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.canlet.2014.10.021","article-title":"Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin","volume":"356","author":"Song","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104997_bib97","author":"Strategies","year":"2020","journal-title":"Cancer Stem Cell Funct. Hepatocell."},{"key":"10.1016\/j.critrevonc.2025.104997_bib98","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","article-title":"Obesity, inflammation, and liver cancer","volume":"56","author":"Sun","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib99","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/mc.23327","article-title":"Autophagy modulates FSS-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells","volume":"60","author":"Su","year":"2021","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2025.104997_bib100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2018.12.047","article-title":"TNF-\u03b1 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma","volume":"40","author":"Tan","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.critrevonc.2025.104997_bib101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2025.104997_bib102","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.7150\/jca.60893","article-title":"Effects of biomechanical forces on the biological behavior of cancer stem cells","volume":"12","author":"Tian","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib103","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.7150\/thno.30958","article-title":"Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis","volume":"9","author":"Tian","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2025.104997_bib104","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gutjnl-2015-309501","article-title":"Tumour initiating cells and IGF\/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma","volume":"66","author":"Tovar","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2025.104997_bib105","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tr\u00e9dan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2025.104997_bib106","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.critrevonc.2025.104997_bib107","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/cancers12020490","article-title":"Stiffer Matrix Accelerates Migration of Hepatocellular Carcinoma Cells through Enhanced Aerobic","volume":"12","author":"Via","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104997_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2015.00115","article-title":"Tumor interstitial fluid formation, characterization, and clinical implications","volume":"5","author":"Wagner","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-022-00881-4","article-title":"Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling","volume":"29","author":"Wang","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413627","article-title":"Chemotherapeutic drug-regulated cytokines might influence therapeutic efficacy in hcc","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib111","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.7150\/ijbs.27055","article-title":"Fluid Shear Stress Promotes Autophagy in Hepatocellular Carcinoma Cells","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104997_bib112","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer drug Resist. (Alhambra Calif. )"},{"key":"10.1016\/j.critrevonc.2025.104997_bib113","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.7150\/jca.51849","article-title":"Acidic extracellular pH induces autophagy to promote anoikis resistance of hepatocellular carcinoma cells via downregulation of miR-3663-3p","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib114","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1186\/s12885-021-08982-3","article-title":"Inhibition of matrix stiffness relating integrin \u03b21 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.37349\/etat.2020.00005","article-title":"The impact of tumour pH on cancer progression: strategies for clinical intervention","volume":"1","author":"Ward","year":"2020","journal-title":"Explor. Target. antiTumor Ther."},{"key":"10.1016\/j.critrevonc.2025.104997_bib116","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12967-022-03778-w","article-title":"Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma","volume":"20","author":"Wei","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.104997_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116117","article-title":"Biomechanical forces and force-triggered drug delivery in tumor neovascularization","volume":"171","author":"Wendong","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.critrevonc.2025.104997_bib118","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.30593","article-title":"Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104997_bib119","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3892\/ol.2016.5476","article-title":"Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17\/IL-17R-JAK2\/STAT3 signaling pathway","volume":"13","author":"Wu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2025.104997_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2025.01.001","article-title":"Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy","author":"Wu","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.critrevonc.2025.104997_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102610","article-title":"The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma","volume":"51","author":"Xia","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2025.104997_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.958720","article-title":"Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities","volume":"12","author":"Xie","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib123","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00262-019-02414-9","article-title":"Activated hepatic stellate cells regulate MDSC migration through the SDF-1\/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma","volume":"68","author":"Xu","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2025.104997_bib124","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yexcr.2017.01.008","article-title":"Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer","volume":"351","author":"Xu","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.critrevonc.2025.104997_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","article-title":"The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets","volume":"21","author":"Yang","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib126","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/19336918.2019.1568141","article-title":"Fluid shear stress induces cell migration and invasion via activating autophagy in HepG2 cells","volume":"13","author":"Yan","year":"2019","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.critrevonc.2025.104997_bib127","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/19336918.2022.2103925","article-title":"Fluid shear stress induces cell migration via RhoA-YAP1-autophagy pathway in liver cancer stem cells","volume":"16","author":"Yan","year":"2022","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.critrevonc.2025.104997_bib128","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.7150\/thno.44789","article-title":"CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2025.104997_bib129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5405\/jmbe.1094","article-title":"Effects of matrix viscoelasticity on HepG2 cell metastasis in a microfluidic device","volume":"33","author":"Ye","year":"2013","journal-title":"J. Med. Biol. Eng."},{"key":"10.1016\/j.critrevonc.2025.104997_bib130","doi-asserted-by":"crossref","first-page":"32221","DOI":"10.18632\/oncotarget.8515","article-title":"Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells","volume":"7","author":"You","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104997_bib131","first-page":"1","article-title":"Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104997_bib132","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14715\/cmb\/2020.66.2.5","article-title":"Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model","volume":"66","author":"Yu","year":"2020","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib133","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/19336918.2017.1319042","article-title":"Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade","volume":"12","author":"Yu","year":"2018","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.critrevonc.2025.104997_bib134","first-page":"91","article-title":"Mechanical forces in tumor angiogenesis","volume":"1092","author":"Zanotelli","year":"2018"},{"key":"10.1016\/j.critrevonc.2025.104997_bib135","first-page":"1","article-title":"Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib136","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3892\/or.2021.7926","article-title":"IL-6 plays a crucial role in epithelial-mesenchymal transition and pro-metastasis induced by sorafenib in liver cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2025.104997_bib137","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2407-13-108","article-title":"Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1\u03b1 in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib138","first-page":"9377","article-title":"Inhibition of the PI3K\/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2025.104997_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.1008902","article-title":"The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104997_bib140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.cellsig.2014.01.026","article-title":"Upregulation of HIF-2\u03b1 induced by sorafenib contributes to the resistance by activating the TGF-\u03b1\/EGFR pathway in hepatocellular carcinoma cells","volume":"26","author":"Zhao","year":"2014","journal-title":"Cell. Signal"},{"key":"10.1016\/j.critrevonc.2025.104997_bib141","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41416-022-01784-9","article-title":"Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression","volume":"127","author":"Zhao","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104997_bib142","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1080\/21655979.2022.2032972","article-title":"Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)\/ nuclear factor -kappa B (NF-\u03baB) pathway","volume":"13","author":"Zhou","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.critrevonc.2025.104997_bib143","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cac2.12294","article-title":"Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun. (London England)"},{"key":"10.1016\/j.critrevonc.2025.104997_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-01873-2","article-title":"Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages","volume":"40","author":"Zhou","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T21:16:49Z","timestamp":1767388609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825003853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":144,"alternative-id":["S1040842825003853"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104997","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver microenvironment and therapy resistance in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104997"}}